Clinical TrialsXenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Xenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Read Post »
Clinical TrialsNovo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Novo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Read Post »
Clinical TrialsSanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Sanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Read Post »
Clinical TrialsModerna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Moderna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Read Post »
Clinical TrialsZai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Zai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Read Post »
Clinical TrialsNuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Nuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Read Post »
Clinical TrialsGigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... GigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... Read Post »
Clinical TrialsRoche advances Elevidys with planned Phase III study to support EMA resubmi... Roche advances Elevidys with planned Phase III study to support EMA resubmi... Read Post »
Clinical TrialsLilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Lilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Read Post »
Clinical TrialsTurning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Turning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Read Post »
Clinical TrialsBayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Bayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Read Post »
Clinical TrialsAicuris Advances Pritelivir with Priority Review and Strong Phase 3 Data Aicuris Advances Pritelivir with Priority Review and Strong Phase 3 Data Read Post »
Clinical TrialsAstellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Astellas Ignites a New Front in KRAS G12D Battle with Phase 3 Entry of Seti... Read Post »
Clinical TrialsINGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence INGREZZA Secures the Long Game as AUSTEDO XR Lags in Treatment Persistence Read Post »
Clinical TrialsAligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Aligos Maps a Wider HBV Horizon as Pevifoscorvir Gains Ground in Phase 2 Read Post »
Clinical TrialsDaraxonrasib Ignites a Survival Breakthrough in Pancreatic Cancer’s Tough... Daraxonrasib Ignites a Survival Breakthrough in Pancreatic Cancer’s Tough... Read Post »
Clinical TrialsSpyre’s SPY001 Pushes the Boundary of UC Care with Promising Induction Re... Spyre’s SPY001 Pushes the Boundary of UC Care with Promising Induction Re... Read Post »
Clinical TrialsIDEAYA and Servier Anchor Darovasertib Combo in Metastatic Uveal Melanoma IDEAYA and Servier Anchor Darovasertib Combo in Metastatic Uveal Melanoma Read Post »
Clinical TrialsEmactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Emactuzumab Breaks the Cycle of Chronic Therapy in TGCT with Phase 3 Result... Read Post »
Clinical TrialsAllogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Allogene Brings CAR T to the Frontline Edge, ALPHA3 Shows Early MRD Win Read Post »
Clinical TrialsOcular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Ocular Therapeutix Shows Durable Wet AMD Control With AXPAXLI Read Post »
Clinical TrialsAbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors AbbVie’s ELAHERE Combo Drives a Targeted Assault on FRα-Positive Tumors Read Post »
Clinical TrialsGSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses GSK’s Mo-Rez Breaks Through in BEHOLD-1 With Strong Early Responses Read Post »
Clinical TrialsKainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Kainova Starts Europe Dosing for DT-7012 in DOMISOL Trial Read Post »
Clinical TrialsCorcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Corcept Delivers Survival Benefit With Relacorilant in Phase 3 ROSELLA Read Post »
Clinical TrialsBioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer BioNTech–DualityBio ADC Delivers Across HER2 Levels in Endometrial Cancer Read Post »
Clinical TrialsFDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study FDA Permits Direct Shift of Ryoncil from IND Stage to Registrational Study Read Post »
Clinical TrialsMilestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Milestone Opens Real-World Chapter for CARDAMYST With RESET-PSVT Read Post »
Clinical TrialsPREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 PREVAIL and KOMET Readouts Set Stage for Alexion at AAN 2026 Read Post »
Clinical TrialsVanda Launches Study of NEREUS™ to Reduce Vomiting With GLP-1 Treatments Vanda Launches Study of NEREUS™ to Reduce Vomiting With GLP-1 Treatments Read Post »
Clinical TrialsNew Data Highlight Regenerative Injectables in Menopause, Weight Loss New Data Highlight Regenerative Injectables in Menopause, Weight Loss Read Post »
Clinical Trials Mergers & AcquisitionsBoehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Boehringer–BioNTech Partner on ES-SCLC Immunotherapy Trial Read Post »
Clinical TrialsPlus Therapeutics Wins FDA Orphan Tag for REYOBIQ Plus Therapeutics Wins FDA Orphan Tag for REYOBIQ Read Post »
Clinical TrialsShionogi Presents Real-World CIRCE Data for Cefiderocol Shionogi Presents Real-World CIRCE Data for Cefiderocol Read Post »
Clinical TrialsInsmed Halts Brensocatib HS Program After Phase 2b Failure Insmed Halts Brensocatib HS Program After Phase 2b Failure Read Post »
Clinical TrialsCatalYm Starts Phase 2b Visugromab Trial in Second-Line HCC CatalYm Starts Phase 2b Visugromab Trial in Second-Line HCC Read Post »
Clinical TrialsNervGen Aligns with FDA on Phase 3 RESTORE Trial of NVG-291 in Chronic Tetr... NervGen Aligns with FDA on Phase 3 RESTORE Trial of NVG-291 in Chronic Tetr... Read Post »
Clinical TrialsSanofi’s Lunsekimig Delivers in Asthma and CRSwNP, Misses Dermatitis Endp... Sanofi’s Lunsekimig Delivers in Asthma and CRSwNP, Misses Dermatitis Endp... Read Post »
Clinical TrialsClimb Bio’s Budoprutug Earns Fast Track Status for pMN Climb Bio’s Budoprutug Earns Fast Track Status for pMN Read Post »
Clinical TrialsTelix Highlights Pipeline Progress, Targets Multiple Regulatory Milestones ... Telix Highlights Pipeline Progress, Targets Multiple Regulatory Milestones ... Read Post »
Clinical Trials Disease & DrugsAmgen Reports Positive Phase 3 Data for Subcutaneous TEPEZZA OBI Amgen Reports Positive Phase 3 Data for Subcutaneous TEPEZZA OBI Read Post »
Clinical TrialsPraxis Reports 77% Seizure Reduction with Elsunersen in Early-Seizure Onset... Praxis Reports 77% Seizure Reduction with Elsunersen in Early-Seizure Onset... Read Post »
Clinical TrialsRisto-cel Demonstrates Consistent Efficacy and Safety in Sickle Cell Diseas... Risto-cel Demonstrates Consistent Efficacy and Safety in Sickle Cell Diseas... Read Post »
Clinical TrialsPriovant Expands Brepocitinib Development Program with Initiation of Phase ... Priovant Expands Brepocitinib Development Program with Initiation of Phase ... Read Post »
Clinical TrialsBridgeBio Reports 54-Month Data, Sustained Survival Benefit with Acoramidis... BridgeBio Reports 54-Month Data, Sustained Survival Benefit with Acoramidis... Read Post »
Clinical TrialsImfinzi – Imjudo Regimen Moves Earlier in HCC with EMERALD-3 Data Imfinzi – Imjudo Regimen Moves Earlier in HCC with EMERALD-3 Data Read Post »
Clinical TrialsInnovent, Ollin Report 20-Week JADE Data Showing OLN324 Durability Edge Ove... Innovent, Ollin Report 20-Week JADE Data Showing OLN324 Durability Edge Ove... Read Post »
Clinical TrialsNovo Nordisk’s Indirect Comparison Data from ORION Puts Wegovy Pill and F... Novo Nordisk’s Indirect Comparison Data from ORION Puts Wegovy Pill and F... Read Post »
Clinical TrialsInnovent’s Mazdutide 9 mg Shows Up to 18.6% Weight Loss in Phase 2 Obesit... Innovent’s Mazdutide 9 mg Shows Up to 18.6% Weight Loss in Phase 2 Obesit... Read Post »
Clinical TrialsPepGen Highlights Promising Safety and Splicing Trends in Phase 2 DM1 Study PepGen Highlights Promising Safety and Splicing Trends in Phase 2 DM1 Study Read Post »
